Evidence map›Paper›PMID 38511153›Full record

ArticleInfection and drug resistance2024

A Cross-Sectional Study on Awareness of Tuberculosis Control Among Post-Treatment Tuberculosis Patients in a City in China.

Rui Jing, Hui Dong, Kun Huang, Zhong Liu, Ran Xue, Yiran Dong, Mei Jiao, Na Li, Yumei Guo, Yun Liu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Rui JingInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0001-5137-231X
Hui DongInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0009-9193-0169
Kun HuangTuberculosis Control Division, Licheng Center for Disease Control and Prevention, Jinan, People's Republic of China.
Zhong LiuInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.
Ran XueInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.
Yiran DongInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0007-2207-0519
Mei JiaoDepartment of Sexually Transmitted Diseases and AIDS Prevention and Control, Lixia Center for Disease Control and Prevention, Jinan, People's Republic of China.
Na LiTuberculosis and Vector Control Division, Shizhong Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0003-8466-3388
Yumei GuoDepartment of Infectious Diseases and Endemic Disease Control, Huaiyin Center for Disease Control and Prevention, Jinan, People's Republic of China.
Yun LiuAIDS Prevention and Control Department, Tianqiao Center for Disease Control and Prevention, Jinan, People's Republic of China.
Wenqian ZhangInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0007-6298-6572
Hongyun SunInstitute for Tuberculosis Control, Jinan Center for Disease Control and Prevention, Jinan, People's Republic of China.ORCID 0009-0003-4146-3589
Shandong Center for Disease Control and Prevention · CNLiaocheng Center for Disease Control and PreventionXian Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to investigate awareness of tuberculosis control among post-treatment tuberculosis patients, in order to provide a basis for future preventive and control work in this population. Patients and Methods: A cross-sectional descriptive study was conducted on post-treatment patients with tuberculosis in seven districts of Jinan City between July 2021 and December 2022. A face-to-face or telephone interviews using structured questionnaires for the research subjects were conducted by data collectors. Analyses were carried out first for all subjects, and then separately for male and female subjects. Results: A total of 837 valid questionnaires were collected, of which 495 were males and 342 were females. The awareness rate of the core TB knowledge was 82.46%. The ≥65 year group in the total group (OR=0.43, 95% CI: (0.28, 0.68)), male (OR=0.47, 95% CI: (0.27, 0.83)) and female group (OR=0.40, 95% CI: (0.19, 0.86)) was lower than that of the control group. Educational level and monthly income are the main factors of TB cognition in total group. People with university or higher education (OR=2.05, 95% CI: (1.38, 3.05)) and with a monthly income of ≥6,000 (OR=1.89, 95% CI: (1.10, 3.25)) had a higher awareness rate. The group with current residence in the city was more aware than the reference group. Conclusion: In the future, the communication of the main transmission route, suspicious symptoms, and cure of TB needs to be strengthened for the post-treatment TB patients. The elderly, those with secondary school education or below, agricultural workers and low-income people are the groups with weak knowledge of TB, and they are also the groups that need to be focused on health education. The above information should be focused on the above groups of people in order to educate them in a way that is easily acceptable to them.

Indexed as

awareness ratecompleted treatment patientslayered analysispulmonary tuberculosis

Identifiers

PMID38511153
PMCPMC10951719
OpenAlexW4392805890

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.